Matthew Pauls - 02 Jul 2026 Form 4 Insider Report for Pelthos Therapeutics Inc. (PTHS)

Reporting relationship: Director
Issuer ticker: PTHS
Reported as of: 02 Jul 2026
Net transaction value: -$20,561
SEC form: 4
Accepted by SEC: 07 Jul 2026, 17:03:38 UTC
Prior SEC filing: 01 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ John M. Gay, by power of attorney

Key filing fact

Matthew Pauls filed Form 4 for Pelthos Therapeutics Inc. (PTHS) on 07 Jul 2026.

Key facts

This page summarizes Matthew Pauls's Form 4 filing for Pelthos Therapeutics Inc. (PTHS).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2026, 17:03.

Change

Previous filing in this sequence was filed on 01 Jul 2026.
Current net transaction value: -$20,561.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001573429 Primary reporting owner

Pauls Matthew

Relationship: Director
Address: C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM
Signature: /s/ John M. Gay, by power of attorney
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PTHS transaction

Common Stock

Sale

Transaction value: $17,989
Shares: -692
Change %: -4.6%
Price: $26.00
Shares after: 14,458
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1, F2

PTHS transaction

Common Stock

Sale

Transaction value: $2,572
Shares: -94
Change %: -0.65%
Price: $27.36
Shares after: 14,364
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $25.58 to $26.24. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $27.20 to $27.63. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.